Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Screen-Weary kids: could a simple supplement ease digital eye strain?

NCT ID NCT06589128

Symptom relief Sponsor: Universiti Sains Malaysia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a daily astaxanthin supplement can reduce digital eye strain in children aged 6–18 who use electronic devices. Seventy children with mild to moderate eye strain will take either astaxanthin or a placebo for 24 weeks. The goal is to see if the supplement improves symptoms like tired or dry eyes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
astaxanthin
What this could lead to
If it works, this could point toward a simple supplement to help children with eye discomfort from screen use.
What could go wrong
This is a small, early-stage trial with only 70 children. The supplement may not work better than a placebo, and results may not apply to all kids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 11 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children with DES (CVS-Q score 6-18) Exclusion Criteria: * Children with CVS-Q score ≥ 19 * Children who wear contact lenses * Children with any diagnosed ocular motility disorder or accommodative/binocular vision issues * Participants who are colour-blind * Participant on any retinols and carotenoid supplements * Participants who have immunosuppressive disorders or are taking immunosuppressive medication * Atopy, allergic disorders * Anaemia * Ophthalmic laser treatment (less than 3 months) * Systemic disease associated with dry eye * Blepharitis * Having liver (chronic liver failure, cirrhosis, all types of hepatitis), kidney (chronic kidney disease, haemodialysis) or haematological (anaemia, thalassemia, haemophilia) disorders * Psychiatric disease/mental retardation (bipolar disorder, depression, schizophrenia) * Cancer (all types), and endocrine disorders (Cushing's disease, gigantism and hyperthyroidism) * Use of steroids, chemotherapy or radiotherapy * Currently under another supplementary program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digital eye strain (DES) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthenopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digital eye strain (DES)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universiti Sains Malaysia Bertam Medical Center

    RECRUITING

    Kepala Batas, Pulau Pinang, 13200, Malaysia

  • Universiti Sains Malaysia Bertam Medical Center

    RECRUITING

    Kepala Batas, Pulau Pinang, 13200, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.